Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation

• Izabela Nowak,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Maria Magott-Procelewska,

  Affiliation Department and Clinic of Nephrology and Transplant Medicine, Faculty of Medicine, Medical University of Wroclaw, Wrocław, Poland

  ⨯
• Agnieszka Kowal,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Maciej Miazga,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Marta Wagner,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Wanda Niepiekło-Miniewska,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Małgorzata Kamińska,

  Affiliation Health Care Center at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland

  ⨯
• Andrzej Wiśniewski,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Edyta Majorczyk,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Marian Klinger,

  Affiliation Department and Clinic of Nephrology and Transplant Medicine, Faculty of Medicine, Medical University of Wroclaw, Wrocław, Poland

  ⨯
• Wioleta Łuszczek,

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• Andrzej Pawlik,

  Affiliation Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Rafał Płoski,

  Affiliation Department of Medical Genetics, Centre of Biostructure Research, Medical University of Warsaw, Warsaw, Poland

  ⨯
• Ewa Barcz,

  Affiliation 1st Chair and Clinic of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland

  ⨯
• David Senitzer,

  Affiliation City of Hope Comprehensive Cancer Center, Duarte, California, United States of America

  ⨯
•  [ ... ],
• Piotr Kuśnierczyk

  * E-mail: pkusnier@iitd.pan.wroc.pl

  Affiliation Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

  ⨯
• [ view all ]
• [ view less ]